Autoimmune Disease 1 Flashcards
1
Q
Diagnostic Criteria of Lupus
A
- Need 4 out of 11: (4 SKIN RASH NIA)
1. Malar Rash - butterfly rash over face, spare labia folds
2. Photosensitivity
3. Oral/Nasal Ulcers
4. Discoid rash - looks like flesh eating and turns into scars - red raised, disc shaped
5. Renal - glomerulonephritis - full house pattern of immunoflourescensce, protein or cellular casts in urine
6. Arthritis - swelling in 2 or more joints without bone damage
7. Serositis - inflammation of serous tissue lining lungs, heart, ab
8. Hematologic cytopenias/hemolytic anemia
9. Neurologic- psychosis or seizures
10. Immunologic- anti DNA or Anti-Sm antibodies
11. ANA - speckled
2
Q
Autoantibodies of SLE
A
- dsDNA - high specificity for glomerulonephritis
- histone - drug induced lupus
- SSA/ Ro - highly associated with neonatal lupus
- SSB/ La
- Sm - high sensitivity for lupus
- RNP
- Anti0-ribosomal P
- Anti-phospholipid
3
Q
Subsets of lupus
A
- discoid
- limited systemic - most common
- ANA, arthritis, rash, ulcers
- Severe systemic -
- renal and CNS symptoms
- Anti-dsDNA involved in glomerulonephritis
- Hematologic
- Drug induced
- Anti-phospholipid antibody syndrom (APS)
- Neonatal - when the anti-ssa is transfered
- can see the anti-Ro deposited btw dermal and epidermal layers
- rash in the skin associated with neonatal lupus
4
Q
Lab markers for SLE
A
- Low complement levels (C3, C4) during flare ups
- 90% are C1q deficient, 75% C4 deficient
- elevated Sed Rate (ESR)
- Eleveated dsDNA levels track disease activity
- urnialysis - proteinuria and RBC casts
5
Q
SLE pathophysiology (mechanism)
A
- BLyS (BAFF) elevated
- stimulates B-cell proliferation, survival
- stimulates Ig Class switching
- up in T-dependent immune responses
- makes B-cells make more anti-self antibodies
- also Type I IFNs genes are upregulated
- more INF alpha which produced by TLR activation
6
Q
treatment for lupus
A
- corticosteroids
- hydroxychloroquine - blocks MHC presentation to T-cells
- Anti-BLys - targets B-cells
- Anti-CD20/ rituximab - CD20 is on B-cells targets them
- Anti-CD22 - epratuzumab - same thing
- Anti-IFN- alpha
7
Q
New Diagnostic Criteria for Primary Sjorgren’s Syndrome
A
2 out of 3 of the following criteria
- Pos. SSA/Ro and/or SSB/La -OR- RF anddd ANA
- Salivary gland biopsy >1
- check for inflammation in small salivary glands -
- look for accumulation of tertiery lymph organ - germinal centers and lymphocytes
- severe dry eye with ocular staining - or Shirmer’s paper in eye test
8
Q
Sjogren’s disease features glandular and extraglandular
A
- Glandular
- Ocular - extreme dry eyes - shrimers test
- Oral - extreme dry mouth - needs liquids to swallow
- Extraglandular
- Skin - cutaneous vasculitis, Raynauds
- Joints - arthritis, RF+, artralgias
- Lungs - interstitial ung disease
- Kienys - interstitial nephritis
- CNS - neuropathy
- General Fatigue
- muscles, hear, GI tract, hematologic
9
Q
Diagnose Sjogren’s
A
- Ocular signs - Schirmer’s test, Rose bengal staining
- histopathology - lymphoid foci
- Salivary gland involvement
- ultrasound, salivary flow, radiographic or floursecent imaging
10
Q
Sjogren’s treatments
A
- Treat dry mouth with salivary replacements, meds to increase saliva
- Dry eyes - artificial tears, cauterize eye drainage ducts, cyclosporin
- Immunosuppressants
- hydroxychloroquine - prevents antigen presentation MHC (glandular and arthritis)
- Rituximab - binds the CD20 on B-cells - help with the oral and ocular dryness
- methotrexate - arthritis
- Azathioprine - helps ILD
11
Q
Other diseases associated with Sjogren’s
A
- Neonatal lupus (Anti-Ro/SSA)
- lymphomas - ** big complication of sjogrens is lymphoma
- Cavities, Thrust, Oral Candidiasis
- decreased saliva not just about keeping mouth moist - lose the histatins and beta-defensins
- IL-17 needed for activation of neutrophils and making these to resist oral candidiasis
12
Q
Autoimmune Epithelitis - sjogren’s
A
- trigger
- epithelial cells attract T-cells - VCAM< MHC, B7, CD40 etc
- attract B-cells CXCL13 chemokine
- epithelial serve as APC and bring immune cells
- BLyS activates B cells to form germinal centers and make antibodies
- BAFF turns B-cells into plasma cells to make antibodies - overproudced by epithelial
- Blys receptors highly expressed on transitional B-cells and required to develope - leads to overproduction of autoantibodies
- salivary lymphoid foci
- have lots of B-cells
- tertiary lymphoid organs with gemr centers and transitional and marginal zone B cells
13
Q
NOD2, ATG16L1
A
- NOD2 - intracellular sensor of bacterial antigens in the gut
- 30-40% of Crohn’s patients have a mutation at NOD2
- ATG16L1
- role in autphagy (lysosomes turnover of organelles)
- ATG16L1 deificient Paneth cells (make anti-microbial in gut) are defective
- NOD2 and ATG16L1 defects predispose IBD by perturbing the nroaml innate immune system to respond toward cmmensal flora required for the maintenance of tolerance
14
Q
Two Drug targets in IBD
A
- Natalizumab
- prevents the interaction btw lymphocyte integrin Alpha4
beta7 and MadCAM-1 adhesion molecule on endothelia cells - prevents the lymphocytes from going to site of
inflammation
- prevents the interaction btw lymphocyte integrin Alpha4
- Infliximab - monoclonal antibody against TNF-alpha
- prevents inflammation
15
Q
Mechanisms of T-helper cells in IBD
A
- Th1 cells produce INF-gamma and TNF-alpha leading to cellular immunity and inflammation
- TH17 cells express IL-17 and IL-22 which increases mucosal immunity
- Th2 - IL-4,5,13 increase humoral immunity
- involved in the IL-23 axis and regulation of IBD susceptibility